{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:56:43Z","timestamp":1790787403583,"version":"4.1.0"},"reference-count":123,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.cyto.2017.09.013","type":"journal-article","created":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T20:33:02Z","timestamp":1512160382000},"page":"154157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":254,"special_numbering":"C","title":["Platelet-derived chemokines in inflammation and atherosclerosis"],"prefix":"10.1016","volume":"122","author":[{"given":"Constantinos","family":"Bakogiannis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Sachse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimon","family":"Stamatelopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Stellos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6917","key":"10.1016\/j.cyto.2017.09.013_b0005","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nature01323","article-title":"Inflammation in atherosclerosis","volume":"420","author":"Libby","year":"2002","journal-title":"Nature"},{"issue":"18","key":"10.1016\/j.cyto.2017.09.013_b0010","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1056\/NEJMra1011670","article-title":"The hemostatic system as a modulator of atherosclerosis","volume":"364","author":"Borissoff","year":"2011","journal-title":"New. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.cyto.2017.09.013_b0015","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1172\/JCI27196","article-title":"Platelets in inflammation and atherogenesis","volume":"115","author":"Gawaz","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.cyto.2017.09.013_b0020","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1161\/01.CIR.96.6.1809","article-title":"Vitronectin receptor (alpha(v)beta3) mediates platelet adhesion to the luminal aspect of endothelial cells: implications for reperfusion in acute myocardial infarction","volume":"96","author":"Gawaz","year":"1997","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.cyto.2017.09.013_b0025","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1084\/jem.187.3.329","article-title":"Adhesion of activated platelets to endothelial cells: evidence for a GPIIbIIIa-dependent bridging mechanism and novel roles for endothelial intercellular adhesion molecule 1 (ICAM-1), alphavbeta3 integrin, and GPIbalpha","volume":"187","author":"Bombeli","year":"1998","journal-title":"J. Exp. Med."},{"issue":"16","key":"10.1016\/j.cyto.2017.09.013_b0030","doi-asserted-by":"crossref","first-page":"7450","DOI":"10.1073\/pnas.92.16.7450","article-title":"Platelets roll on stimulated endothelium in vivo: an interaction mediated by endothelial P-selectin","volume":"92","author":"Frenette","year":"1995","journal-title":"Proc. Nat. Acad. Sci. U.S.A."},{"issue":"2","key":"10.1016\/j.cyto.2017.09.013_b0035","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1182\/blood.V92.2.507","article-title":"Platelet-endothelial cell interactions during ischemia\/reperfusion: the role of P-selectin","volume":"92","author":"Massberg","year":"1998","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.cyto.2017.09.013_b0040","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1161\/ATVBAHA.113.301655","article-title":"Chemokines in atherosclerosis","volume":"34","author":"Zernecke","year":"2014","journal-title":"Proc. ResumedArterioscl. Thromb. Vasc. Biol."},{"issue":"8","key":"10.1016\/j.cyto.2017.09.013_b0045","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.jacc.2009.03.076","article-title":"The CD40\/CD40 ligand system: linking inflammation with atherothrombosis","volume":"54","author":"Antoniades","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"issue":"10","key":"10.1016\/j.cyto.2017.09.013_b0050","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1182\/blood.V99.10.3613","article-title":"Platelet factor 4 binds to low-density lipoprotein receptors and disrupts the endocytic machinery, resulting in retention of low-density lipoprotein on the cell surface","volume":"99","author":"Sachais","year":"2002","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.cyto.2017.09.013_b0055","doi-asserted-by":"crossref","first-page":"6187","DOI":"10.1074\/jbc.M208894200","article-title":"Platelet factor 4 enhances the binding of oxidized low-density lipoprotein to vascular wall cells","volume":"278","author":"Nassar","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.cyto.2017.09.013_b0060","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1055\/s-0030-1251497","article-title":"Platelet aggregates-induced human CD34+progenitor cell proliferation and differentiation to macrophages and foam cells is mediated by stromal cell derived factor 1 in vitro","volume":"36","author":"Stellos","year":"2010","journal-title":"Semin. Thromb. Hemost."},{"issue":"6625","key":"10.1016\/j.cyto.2017.09.013_b0065","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/386616a0","article-title":"Release of gelatinase A during platelet activation mediates aggregation","volume":"386","author":"Sawicki","year":"1997","journal-title":"Nature"},{"issue":"16","key":"10.1016\/j.cyto.2017.09.013_b0070","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1161\/01.CIR.0000033597.45947.0F","article-title":"Engagement of glycoprotein IIb\/IIIa (alpha(IIb)beta3) on platelets upregulates CD40L and triggers CD40L-dependent matrix degradation by endothelial cells","volume":"106","author":"May","year":"2002","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.cyto.2017.09.013_b0075","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1161\/ATVBAHA.115.303395","article-title":"Purinergic Receptors in Thrombosis and Inflammation","volume":"35","author":"Hechler","year":"2015","journal-title":"Arterioscl. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.cyto.2017.09.013_b0080","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1161\/CIRCULATIONAHA.107.762690","article-title":"Platelet P2Y(12) receptor influences the vessel wall response to arterial injury and thrombosis","volume":"119","author":"Evans","year":"2009","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.cyto.2017.09.013_b0085","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1161\/ATVBAHA.111.239095","article-title":"Roles of purinergic receptor P2Y, G protein-coupled 12 in the development of atherosclerosis in apolipoprotein E-deficient mice","volume":"32","author":"Li","year":"2012","journal-title":"Arterioscl. Thromb. Vasc. Biol."},{"issue":"11","key":"10.1016\/j.cyto.2017.09.013_b0090","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1182\/blood.V94.11.3829","article-title":"Fibrinogen deposition at the postischemic vessel wall promotes platelet adhesion during ischemia-reperfusion in vivo","volume":"94","author":"Massberg","year":"1999","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.cyto.2017.09.013_b0095","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1084\/jem.20020945","article-title":"A crucial role of glycoprotein VI for platelet recruitment to the injured arterial wall in vivo","volume":"197","author":"Massberg","year":"2003","journal-title":"J. Exp. Med."},{"issue":"8","key":"10.1016\/j.cyto.2017.09.013_b0100","first-page":"898","article-title":"Human atheromatous plaques stimulate thrombus formation by activating platelet glycoprotein VI","volume":"19","author":"Penz","year":"2005","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"issue":"5","key":"10.1016\/j.cyto.2017.09.013_b0105","doi-asserted-by":"crossref","first-page":"589","DOI":"10.2174\/157016112801784468","article-title":"Platelets in atherothrombosis \u2013 diagnostic and prognostic value of platelet activation in patients with atherosclerotic diseases","volume":"10","author":"Bigalke","year":"2012","journal-title":"Curr. Vasc. Pharmacol."},{"issue":"4","key":"10.1016\/j.cyto.2017.09.013_b0110","first-page":"227","article-title":"Glycoprotein VI as a prognostic biomarker for cardiovascular death in patients with symptomatic coronary artery disease","volume":"99","author":"Bigalke","year":"2010","journal-title":"Clin. Res. Cardiol. Off. J. Ger. Cardiac Soc."},{"issue":"7","key":"10.1016\/j.cyto.2017.09.013_b0115","doi-asserted-by":"crossref","first-page":"560","DOI":"10.3109\/09537104.2012.746455","article-title":"Plasma levels of soluble glycoprotein VI (sGPVI) are associated with ischemic stroke","volume":"24","author":"Wurster","year":"2013","journal-title":"Platelets"},{"issue":"1","key":"10.1016\/j.cyto.2017.09.013_b0120","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1468-1331.2009.02754.x","article-title":"Expression of platelet glycoprotein VI is associated with transient ischemic attack and stroke","volume":"17","author":"Bigalke","year":"2010","journal-title":"Eur. J. Neurol."},{"issue":"5","key":"10.1016\/j.cyto.2017.09.013_b0125","doi-asserted-by":"crossref","first-page":"e184","DOI":"10.1016\/j.thromres.2010.01.005","article-title":"Platelet glycoprotein VI (GPVI) for early identification of acute coronary syndrome in patients with chest pain","volume":"125","author":"Bigalke","year":"2010","journal-title":"Thromb. Res."},{"issue":"2","key":"10.1016\/j.cyto.2017.09.013_b0130","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ijcard.2009.12.026","article-title":"Glycoprotein VI for diagnosis of acute coronary syndrome when ECG is ambiguous","volume":"149","author":"Bigalke","year":"2011","journal-title":"Int. J. Cardiol."},{"issue":"6","key":"10.1016\/j.cyto.2017.09.013_b0135","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nri2096","article-title":"The role of junctional adhesion molecules in vascular inflammation","volume":"7","author":"Weber","year":"2007","journal-title":"Nature Rev. Immunol."},{"issue":"4","key":"10.1016\/j.cyto.2017.09.013_b0140","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1161\/CIRCRESAHA.116.304035","article-title":"Hyperreactivity of junctional adhesion molecule A-deficient platelets accelerates atherosclerosis in hyperlipidemic mice","volume":"116","author":"Karshovska","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.cyto.2017.09.013_b0145","article-title":"Deletion of junctional adhesion molecule A from platelets increases early-stage neointima formation after wire injury in hyperlipidemic mice","author":"Zhao","year":"2017","journal-title":"J. Cell. Mol. Med."},{"issue":"6","key":"10.1016\/j.cyto.2017.09.013_b0150","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1161\/ATVBAHA.110.204370","article-title":"Junctional adhesion molecule A expressed on human CD34+cells promotes adhesion on vascular wall and differentiation into endothelial progenitor cells","volume":"30","author":"Stellos","year":"2010","journal-title":"Arteriosc. Thromb. Vasc. Biol."},{"issue":"1\u20132","key":"10.1016\/j.cyto.2017.09.013_b0155","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000337596","article-title":"Expression of junctional adhesion molecule-C on the surface of platelets supports adhesion, but not differentiation, of human CD34 cells in vitro","volume":"29","author":"Stellos","year":"2012","journal-title":"Cell. Physiol. Biochem. Int. J. Exp. Cell. Physiol. Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.cyto.2017.09.013_b0160","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1467-789X.2011.00930.x","article-title":"Platelet activation in obesity and metabolic syndrome","volume":"13","author":"Santilli","year":"2012","journal-title":"Obesity Rev. Off. J. Int. Assoc. Study Obesity"},{"issue":"6","key":"10.1016\/j.cyto.2017.09.013_b0165","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.numecd.2009.01.006","article-title":"Platelet dysfunction in central obesity","volume":"19","author":"Anfossi","year":"2009","journal-title":"Nutr. Meta. Cardiovasc. Dis. NMCD"},{"issue":"8","key":"10.1016\/j.cyto.2017.09.013_b0170","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.freeradbiomed.2012.02.012","article-title":"Plasma levels of soluble CD36, platelet activation, inflammation, and oxidative stress are increased in type 2 diabetic patients","volume":"52","author":"Liani","year":"2012","journal-title":"Free Radical Biol. Med."},{"key":"10.1016\/j.cyto.2017.09.013_b0175","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.ijcard.2015.04.052","article-title":"Prognostic impact of high residual platelet reactivity after chronic total occlusion percutaneous coronary intervention in patients with diabetes mellitus","volume":"201","author":"Valenti","year":"2015","journal-title":"Int. J. Cardiol."},{"issue":"3","key":"10.1016\/j.cyto.2017.09.013_b0180","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1365-2362.2004.01320.x","article-title":"Improved metabolic control decreases platelet activation markers in patients with type-2 diabetes","volume":"34","author":"Eibl","year":"2004","journal-title":"Eur. J. Clin Invest."},{"issue":"2","key":"10.1016\/j.cyto.2017.09.013_b0185","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1160\/TH08-12-0796","article-title":"Microparticles as new markers of cardiovascular risk in diabetes and beyond","volume":"116","author":"Santilli","year":"2016","journal-title":"Thromb. Haemostasis"},{"issue":"1","key":"10.1016\/j.cyto.2017.09.013_b0190","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.amjcard.2006.01.054","article-title":"Endothelial microparticles and platelet and leukocyte activation in patients with the metabolic syndrome","volume":"98","author":"Arteaga","year":"2006","journal-title":"Am. J. Cardiol."},{"issue":"8","key":"10.1016\/j.cyto.2017.09.013_b0195","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1177\/1076029612467845","article-title":"Elevated RANTES level is associated with metabolic syndrome and correlated with activated platelets associated markers in healthy younger men","volume":"20","author":"Ueba","year":"2014","journal-title":"Clin. Appl. Thromb\/Hemostasis Off. J. Int. Acad. Clin. Appl. Thromb.\/Hemostasis"},{"issue":"3","key":"10.1016\/j.cyto.2017.09.013_b0200","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.thromres.2014.12.030","article-title":"Metabolic syndrome, platelet activation and the development of transient ischemic attack or thromboembolic stroke","volume":"135","author":"van Rooy","year":"2015","journal-title":"Thrombosis Res."},{"issue":"2","key":"10.1016\/j.cyto.2017.09.013_b0205","doi-asserted-by":"crossref","first-page":"79","DOI":"10.5152\/eurasianjmed.2015.43","article-title":"Assessment of mean platelet volume in patients with resistant hypertension controlled hypertension and normotensives","volume":"47","author":"Surgit","year":"2015","journal-title":"Eurasian J. Med."},{"issue":"9","key":"10.1016\/j.cyto.2017.09.013_b0210","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/hr.2012.62","article-title":"Increased platelet volume in a general population with prehypertension: a cross-sectional study of 80 545 participants from China","volume":"35","author":"Cao","year":"2012","journal-title":"Hypertens. Res. Off. J. Jpn. Soc. Hypertens."},{"key":"10.1016\/j.cyto.2017.09.013_b0215","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.thromres.2016.12.003","article-title":"Platelets modulate endothelial cell response to dynamic shear stress through PECAM-1","volume":"150","author":"Meza","year":"2017","journal-title":"Thromb. Res."},{"issue":"2","key":"10.1016\/j.cyto.2017.09.013_b0220","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/cvr\/cvt110","article-title":"The effects of arterial flow on platelet activation, thrombus growth, and stabilization","volume":"99","author":"Cosemans","year":"2013","journal-title":"Cardiovasc. Res."},{"issue":"11","key":"10.1016\/j.cyto.2017.09.013_b0225","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1161\/ATVBAHA.115.306359","article-title":"Chemokines","volume":"35","author":"van der Vorst","year":"2015","journal-title":"Arterioscl. Thromb. Vasc. Biol."},{"issue":"13","key":"10.1016\/j.cyto.2017.09.013_b0230","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1161\/01.CIR.103.13.1772","article-title":"RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium","volume":"103","author":"von Hundelshausen","year":"2001","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.cyto.2017.09.013_b0235","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nm810","article-title":"Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E","volume":"9","author":"Huo","year":"2003","journal-title":"Nature Med."},{"issue":"2","key":"10.1016\/j.cyto.2017.09.013_b0240","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1161\/01.RES.0000109793.17591.4E","article-title":"Antagonism of RANTES receptors reduces atherosclerotic plaque formation in mice","volume":"94","author":"Veillard","year":"2004","journal-title":"Circ. Res."},{"issue":"10","key":"10.1016\/j.cyto.2017.09.013_b0245","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1161\/CIRCRESAHA.116.308648","article-title":"CCR5+T-bet+FoxP3+Effector CD4T cells drive atherosclerosis","volume":"118","author":"Li","year":"2016","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.cyto.2017.09.013_b0250","first-page":"1277","article-title":"Inflammatory role and prognostic value of platelet chemokines in acute coronary syndrome","volume":"112","author":"Blanchet","year":"2014","journal-title":"Thromb. Haemostasis"},{"issue":"4","key":"10.1016\/j.cyto.2017.09.013_b0255","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1161\/01.ATV.0000258789.21585.76","article-title":"Low plasma RANTES levels are an independent predictor of cardiac mortality in patients referred for coronary angiography","volume":"27","author":"Cavusoglu","year":"2007","journal-title":"Arterioscl Thromb. Vasc. Biol."},{"issue":"7","key":"10.1016\/j.cyto.2017.09.013_b0260","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1042\/CS20150666","article-title":"Emerging importance of chemokine receptor CXCR3 and its ligands in cardiovascular diseases","volume":"130","author":"Altara","year":"2016","journal-title":"Clin. Sci. (Lond)"},{"issue":"6\u20137","key":"10.1016\/j.cyto.2017.09.013_b0265","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ejcb.2010.12.002","article-title":"Molecular pathways of platelet factor 4\/CXCL4 signaling","volume":"90","author":"Kasper","year":"2011","journal-title":"Eur. J. Cell Biol."},{"issue":"6","key":"10.1016\/j.cyto.2017.09.013_b0270","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1160\/TH12-11-0819","article-title":"CD4+T cells in atherosclerosis: regulation by platelets","volume":"109","author":"Li","year":"2013","journal-title":"Thromb. Haemostasis"},{"issue":"1","key":"10.1016\/j.cyto.2017.09.013_b0275","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1161\/CIRCRESAHA.109.199505","article-title":"CXCL4 downregulates the atheroprotective hemoglobin receptor CD163 in human macrophages","volume":"106","author":"Gleissner","year":"2010","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.cyto.2017.09.013_b0280","first-page":"1108","article-title":"Elimination of platelet factor 4 (PF4) from platelets reduces atherosclerosis in C57Bl\/6 and apoE\u2212\/\u2212 mice","volume":"98","author":"Sachais","year":"2007","journal-title":"Thromb. Haemostasis"},{"issue":"6","key":"10.1016\/j.cyto.2017.09.013_b0285","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1160\/TH03-02-0069","article-title":"Platelet factor 4 localization in carotid atherosclerotic plaques: correlation with clinical parameters","volume":"90","author":"Pitsilos","year":"2003","journal-title":"Thromb. Haemostasis"},{"key":"10.1016\/j.cyto.2017.09.013_b0290","doi-asserted-by":"crossref","unstructured":"E.J. Goetzl, J.B. Schwartz, M. Mustapic, I.V. Lobach, R. Daneman, E.L. Abner, G.A. Jicha, Altered cargo proteins of human plasma endothelial cell-derived exosomes in atherosclerotic cerebrovascular disease, FASEB J. Off. Pub. Fed. Am. Soc. Exp. Biol. 2017.","DOI":"10.1096\/fj.201700149"},{"issue":"1","key":"10.1016\/j.cyto.2017.09.013_b0295","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1538-7836.2010.04119.x","article-title":"CXCL4L1 inhibits angiogenesis and induces undirected endothelial cell migration without affecting endothelial cell proliferation and monocyte recruitment","volume":"9","author":"Sarabi","year":"2011","journal-title":"J. Thromb. Haemostasis JTH"},{"issue":"2","key":"10.1016\/j.cyto.2017.09.013_b0300","doi-asserted-by":"crossref","first-page":"e31343","DOI":"10.1371\/journal.pone.0031343","article-title":"PF-4var\/CXCL4L1 predicts outcome in stable coronary artery disease patients with preserved left ventricular function","volume":"7","author":"De Sutter","year":"2012","journal-title":"PloS one"},{"issue":"11","key":"10.1016\/j.cyto.2017.09.013_b0305","doi-asserted-by":"crossref","first-page":"e0166006","DOI":"10.1371\/journal.pone.0166006","article-title":"CXCL4 and CXCL4L1 differentially affect monocyte survival and dendritic cell differentiation and phagocytosis","volume":"11","author":"Gouwy","year":"2016","journal-title":"PloS one"},{"issue":"4","key":"10.1016\/j.cyto.2017.09.013_b0310","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1161\/ATVBAHA.112.300329","article-title":"Peptide inhibitor of CXCL4-CCL5 heterodimer formation MKEY, inhibits experimental aortic aneurysm initiation and progression","volume":"33","author":"Iida","year":"2013","journal-title":"Arterioscl. Thromb. Vasc. Biol."},{"issue":"9","key":"10.1016\/j.cyto.2017.09.013_b0315","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003615","article-title":"MKEY, a peptide inhibitor of CXCL4-CCL5 heterodimer formation, protects against stroke in mice","volume":"5","author":"Fan","year":"2016","journal-title":"J. Am. Heart Assoc."},{"issue":"384","key":"10.1016\/j.cyto.2017.09.013_b0320","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aah6650","article-title":"Chemokine interactome mapping enables tailored intervention in acute and chronic inflammation","volume":"9","author":"von Hundelshausen","year":"2017","journal-title":"Sci. Translational Med."},{"issue":"2","key":"10.1016\/j.cyto.2017.09.013_b0325","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.bbamcr.2015.11.028","article-title":"CXCL12 regulates platelet activation via the regulator of G-protein signaling 16","volume":"1863","author":"Karim","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.cyto.2017.09.013_b0330","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cellsig.2014.09.021","article-title":"SDF-1alpha is a novel autocrine activator of platelets operating through its receptor CXCR4","volume":"27","author":"Walsh","year":"2015","journal-title":"Cell. Signal."},{"key":"10.1016\/j.cyto.2017.09.013_b0335","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3389\/fimmu.2015.00373","article-title":"MIF and CXCL12 in cardiovascular diseases: functional differences and similarities","volume":"6","author":"van der Vorst","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cyto.2017.09.013_b0340","doi-asserted-by":"crossref","first-page":"e1989","DOI":"10.1038\/cddis.2015.233","article-title":"Platelet-derived CXCL12 regulates monocyte function, survival, differentiation into macrophages and foam cells through differential involvement of CXCR4-CXCR7","volume":"6","author":"Chatterjee","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cyto.2017.09.013_b0345","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.thromres.2016.06.006","article-title":"Evidence of an interaction between TGF-beta1 and the SDF-1\/CXCR4\/CXCR7 axis in human platelets","volume":"144","author":"Rath","year":"2016","journal-title":"Thromb. Res."},{"issue":"2","key":"10.1016\/j.cyto.2017.09.013_b0350","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1161\/CIRCULATIONAHA.107.714691","article-title":"Platelet-derived stromal cell-derived factor-1 regulates adhesion and promotes differentiation of human CD34+cells to endothelial progenitor cells","volume":"117","author":"Stellos","year":"2008","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.cyto.2017.09.013_b0355","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/eurheartj\/ehn566","article-title":"Expression of stromal-cell-derived factor-1 on circulating platelets is increased in patients with acute coronary syndrome and correlates with the number of CD34+progenitor cells","volume":"30","author":"Stellos","year":"2009","journal-title":"Eur. heart J."},{"issue":"4","key":"10.1016\/j.cyto.2017.09.013_b0360","doi-asserted-by":"crossref","first-page":"e486","DOI":"10.1016\/j.ejrad.2011.06.019","article-title":"Association of platelet-SDF-1 with hemodynamic function and infarct size using cardiac MR in patients with AMI","volume":"81","author":"Geisler","year":"2012","journal-title":"Eur. J. Radiol."},{"issue":"32","key":"10.1016\/j.cyto.2017.09.013_b0365","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1093\/eurheartj\/eht131","article-title":"Circulating platelet-progenitor cell coaggregate formation is increased in patients with acute coronary syndromes and augments recruitment of CD34+cells in the ischaemic microcirculation","volume":"34","author":"Stellos","year":"2013","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.cyto.2017.09.013_b0370","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1046\/j.1538-7836.2003.00065.x","article-title":"CXC-chemokines in coronary artery disease: possible pathogenic role of interactions between oxidized low-density lipoprotein, platelets and peripheral blood mononuclear cells","volume":"1","author":"Holm","year":"2003","journal-title":"J. Thromb. Haemostasis JTH"},{"issue":"3","key":"10.1016\/j.cyto.2017.09.013_b0375","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI66580","article-title":"CXCL5 limits macrophage foam cell formation in atherosclerosis","volume":"123","author":"Rousselle","year":"2013","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.cyto.2017.09.013_b0380","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/j.1365-2265.2011.04119.x","article-title":"Serum CXC ligand 5 is a new marker of subclinical atherosclerosis in type 2 diabetes","volume":"75","author":"Chen","year":"2011","journal-title":"Clin. Endocrinol."},{"issue":"6","key":"10.1016\/j.cyto.2017.09.013_b0385","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1160\/TH10-10-0689","article-title":"CXCL16 is a novel scavenger receptor on platelets and is associated with acute coronary syndrome","volume":"105","author":"Seizer","year":"2011","journal-title":"Thromb. Haemostasis"},{"issue":"2","key":"10.1016\/j.cyto.2017.09.013_b0390","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1160\/TH14-11-0911","article-title":"Platelets from flowing blood attach to the inflammatory chemokine CXCL16 expressed in the endothelium of the human vessel wall","volume":"114","author":"Meyer Dos Santos","year":"2015","journal-title":"Thromb. Haemostasis"},{"key":"10.1016\/j.cyto.2017.09.013_b0395","article-title":"CXCL16\/CXCR6-mediated adhesion of human peripheral blood mononuclear cells to inflamed endothelium","author":"Linke","year":"2017","journal-title":"Cytokine"},{"issue":"6","key":"10.1016\/j.cyto.2017.09.013_b0400","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1161\/CIRCULATIONAHA.105.540583","article-title":"Targeted disruption of the scavenger receptor and chemokine CXCL16 accelerates atherosclerosis","volume":"114","author":"Aslanian","year":"2006","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.cyto.2017.09.013_b0405","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.cyto.2010.11.016","article-title":"Overexpression of CXCL16 promotes a vulnerable plaque phenotype in Apolipoprotein E-Knockout Mice","volume":"53","author":"Yi","year":"2011","journal-title":"Cytokine"},{"issue":"4","key":"10.1016\/j.cyto.2017.09.013_b0410","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jacc.2006.09.034","article-title":"CXCL16 is a marker of inflammation, atherosclerosis, and acute coronary syndromes in humans","volume":"49","author":"Lehrke","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"issue":"25","key":"10.1016\/j.cyto.2017.09.013_b0415","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1161\/CIRCULATIONAHA.108.806877","article-title":"Soluble CXCL16 predicts long-term mortality in acute coronary syndromes","volume":"119","author":"Jansson","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.cyto.2017.09.013_b0420","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.atherosclerosis.2015.11.022","article-title":"Soluble CXCL16 and risk of myocardial infarction: the HUNT study in Norway","volume":"244","author":"Laugsand","year":"2016","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.cyto.2017.09.013_b0425","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.atherosclerosis.2011.10.004","article-title":"Soluble CXCL16 and long-term outcome in acute ischemic stroke","volume":"220","author":"Ueland","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cyto.2017.09.013_b0430","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.atherosclerosis.2016.03.004","article-title":"Possible roles of platelet-derived microparticles in atherosclerosis","volume":"248","author":"Wang","year":"2016","journal-title":"Atherosclerosis"},{"issue":"7","key":"10.1016\/j.cyto.2017.09.013_b0435","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1161\/01.ATV.0000170133.43608.37","article-title":"Platelet microparticles: a transcellular delivery system for RANTES promoting monocyte recruitment on endothelium","volume":"25","author":"Mause","year":"2005","journal-title":"Arterioscl. Thromb. Vasc. Biol."},{"issue":"2","key":"10.1016\/j.cyto.2017.09.013_b0440","doi-asserted-by":"crossref","first-page":"137","DOI":"10.5482\/HAMO-14-11-0058","article-title":"Platelet-derived chemokines in atherosclerosis","volume":"35","author":"Duchene","year":"2015","journal-title":"Hamostaseologie"},{"issue":"11","key":"10.1016\/j.cyto.2017.09.013_b0445","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1161\/ATVBAHA.108.169417","article-title":"Platelet chemokines in vascular disease","volume":"28","author":"Gleissner","year":"2008","journal-title":"Arterioscl. Thromb. Vasc. Biol."},{"issue":"4","key":"10.1016\/j.cyto.2017.09.013_b0450","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3109\/09537104.2015.1010441","article-title":"Platelets in inflammation and infection","volume":"26","author":"Jenne","year":"2015","journal-title":"Platelets"},{"issue":"4","key":"10.1016\/j.cyto.2017.09.013_b0455","first-page":"666","article-title":"The role of platelets in sepsis","volume":"112","author":"de Stoppelaar","year":"2014","journal-title":"Thromb. Haemostasis"},{"issue":"7","key":"10.1016\/j.cyto.2017.09.013_b0460","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/eci.12101","article-title":"Platelets and autoimmunity","volume":"43","author":"Habets","year":"2013","journal-title":"Eur. J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.cyto.2017.09.013_b0465","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1007\/s10067-007-0550-0","article-title":"The significance of platelet activation in rheumatoid arthritis","volume":"26","author":"Wang","year":"2007","journal-title":"Clin. Rheumatol."},{"issue":"2","key":"10.1016\/j.cyto.2017.09.013_b0470","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1080\/09537100701210057","article-title":"Increased platelet activation markers in rheumatoid arthritis: are they related with subclinical atherosclerosis?","volume":"19","author":"Pamuk","year":"2008","journal-title":"Platelets"},{"issue":"6","key":"10.1016\/j.cyto.2017.09.013_b0475","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1002\/art.10287","article-title":"CD154-CD40 interactions mediate differentiation to plasma cells in healthy individuals and persons with systemic lupus erythematosus","volume":"46","author":"Grammer","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cyto.2017.09.013_b0480","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1742-2094-5-27","article-title":"Evidence of platelet activation in multiple sclerosis","volume":"5","author":"Sheremata","year":"2008","journal-title":"J. Neuroinflammation"},{"issue":"5","key":"10.1016\/j.cyto.2017.09.013_b0485","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/nm0502-500","article-title":"Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis","volume":"8","author":"Lock","year":"2002","journal-title":"Nature Med."},{"issue":"5","key":"10.1016\/j.cyto.2017.09.013_b0490","doi-asserted-by":"crossref","first-page":"626","DOI":"10.2174\/157016112801784657","article-title":"Platelet activation in Alzheimer's disease: from pathophysiology to clinical value","volume":"10","author":"Laske","year":"2012","journal-title":"Current vascular pharmacology"},{"issue":"1","key":"10.1016\/j.cyto.2017.09.013_b0495","doi-asserted-by":"crossref","first-page":"152","DOI":"10.2174\/157016111201140327164641","article-title":"Association of platelet activation with vascular cognitive impairment: implications in dementia development?","volume":"12","author":"Stellos","year":"2014","journal-title":"Curr. Vasc. Pharmacol."},{"issue":"9","key":"10.1016\/j.cyto.2017.09.013_b0500","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.jpsychires.2007.07.017","article-title":"Association of platelet-derived soluble glycoprotein VI in plasma with Alzheimer's disease","volume":"42","author":"Laske","year":"2008","journal-title":"J. Psychia. Res."},{"issue":"3","key":"10.1016\/j.cyto.2017.09.013_b0505","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/01.mbc.0000046182.72384.ab","article-title":"Aspirin inhibits surface glycoprotein IIb\/IIIa, P-selectin, CD63, and CD107a receptor expression on human platelets","volume":"14","author":"McKenzie","year":"2003","journal-title":"Blood Coagul. Fibrinolysis Int. J. Haemostasis Thromb."},{"issue":"5","key":"10.1016\/j.cyto.2017.09.013_b0510","first-page":"2058","article-title":"Human plasma platelet-derived exosomes: effects of aspirin","volume":"30","author":"Goetzl","year":"2016","journal-title":"FASEB J. Off. Pub. Fed. Am. Soc. Exp. Biol."},{"issue":"7","key":"10.1016\/j.cyto.2017.09.013_b0515","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1161\/01.ATV.0000225288.74170.dc","article-title":"Clopidogrel improves systemic endothelial nitric oxide bioavailability in patients with coronary artery disease: evidence for antioxidant and antiinflammatory effects","volume":"26","author":"Heitzer","year":"2006","journal-title":"Arterioscl. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.cyto.2017.09.013_b0520","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1161\/CIRCRESAHA.116.308537","article-title":"Pleiotropic effects of statins on the cardiovascular system","volume":"120","author":"Oesterle","year":"2017","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.cyto.2017.09.013_b0525","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1161\/ATVBAHA.106.128793","article-title":"Fluvastatin alters platelet aggregability in patients with hypercholesterolemia: possible improvement of intraplatelet redox imbalance via HMG-CoA reductase","volume":"27","author":"Haramaki","year":"2007","journal-title":"Arterioscl. Thromb. Vasc. Biol."},{"issue":"4","key":"10.1016\/j.cyto.2017.09.013_b0530","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00380-008-1038-9","article-title":"Atorvastatin induces associated reductions in platelet P-selectin, oxidized low-density lipoprotein, and interleukin-6 in patients with coronary artery diseases","volume":"23","author":"Oka","year":"2008","journal-title":"Heart Vessels"},{"issue":"9","key":"10.1016\/j.cyto.2017.09.013_b0535","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1373\/clinchem.2003.030940","article-title":"Early effect of pravastatin on serum soluble CD40L, matrix metalloproteinase-9, and C-reactive protein in patients with acute myocardial infarction","volume":"50","author":"Li","year":"2004","journal-title":"Clin. Chem."},{"issue":"4","key":"10.1016\/j.cyto.2017.09.013_b0540","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1161\/01.CIR.0000025419.95769.F0","article-title":"Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia: effects of statin therapy","volume":"106","author":"Cipollone","year":"2002","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.cyto.2017.09.013_b0545","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1160\/TH05-01-0067","article-title":"Early antithrombotic and anti-inflammatory effects of simvastatin versus fenofibrate in patients with hypercholesterolemia","volume":"94","author":"Undas","year":"2005","journal-title":"Thromb. Haemostasis"},{"issue":"2","key":"10.1016\/j.cyto.2017.09.013_b0550","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0735-1097(02)02718-3","article-title":"Raised serum levels of soluble CD40 ligand in patients with familial hypercholesterolemia: downregulatory effect of statin therapy","volume":"41","author":"Semb","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.cyto.2017.09.013_b0555","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.atherosclerosis.2016.12.019","article-title":"Platelet tissue factor activity and membrane cholesterol are increased in hypercholesterolemia and normalized by rosuvastatin, but not by atorvastatin","volume":"257","author":"Panes","year":"2016","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.cyto.2017.09.013_b0560","doi-asserted-by":"crossref","first-page":"e327","DOI":"10.1016\/j.thromres.2010.03.019","article-title":"The influence of direct thrombin inhibitors on the formation of platelet-leukocyte aggregates and tissue factor expression","volume":"126","author":"Christersson","year":"2010","journal-title":"Thromb. Res."},{"issue":"1","key":"10.1016\/j.cyto.2017.09.013_b0565","doi-asserted-by":"crossref","first-page":"154","DOI":"10.5114\/aoms.2014.40742","article-title":"Thrombin inhibition by dabigatran attenuates atherosclerosis in ApoE deficient mice","volume":"10","author":"Pingel","year":"2014","journal-title":"Archi. Med. Sci. AMS"},{"issue":"6","key":"10.1016\/j.cyto.2017.09.013_b0570","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1177\/1074248415578172","article-title":"Effects of Rivaroxaban on Platelet Activation and Platelet-Coagulation Pathway Interaction Vitro and In Vivo Studies","volume":"20","author":"Perzborn","year":"2015","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.cyto.2017.09.013_b0575","doi-asserted-by":"crossref","first-page":"e0171486","DOI":"10.1371\/journal.pone.0171486","article-title":"Differential inhibitory action of apixaban on platelet and fibrin components of forming thrombi: Studies with circulating blood and in a platelet-based model of thrombin generation","volume":"12","author":"Pujadas-Mestres","year":"2017","journal-title":"PloS one"},{"issue":"4","key":"10.1016\/j.cyto.2017.09.013_b0580","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1161\/ATVBAHA.113.302613","article-title":"Deficiency of ATP-binding cassette transporter B6 in megakaryocyte progenitors accelerates atherosclerosis in mice","volume":"34","author":"Murphy","year":"2014","journal-title":"Arterioscl. Thromb. Vasc. Biol."},{"issue":"11","key":"10.1016\/j.cyto.2017.09.013_b0585","doi-asserted-by":"crossref","first-page":"e0141693","DOI":"10.1371\/journal.pone.0141693","article-title":"CXCL4 plasma levels are not associated with the extent of coronary artery disease or with coronary plaque morphology","volume":"10","author":"Erbel","year":"2015","journal-title":"PloS one"},{"issue":"1","key":"10.1016\/j.cyto.2017.09.013_b0590","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1080\/09537104.2016.1203399","article-title":"Platelet surface expression of SDF-1 is associated with clinical outcomes in the patients with cardiovascular disease","volume":"28","author":"Rath","year":"2017","journal-title":"Platelets"},{"issue":"5","key":"10.1016\/j.cyto.2017.09.013_b0595","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.4049\/jimmunol.169.5.2602","article-title":"Platelet-derived chemokines CXC chemokine ligand (CXCL)7, connective tissue-activating peptide III, and CXCL4 differentially affect and cross-regulate neutrophil adhesion and transendothelial migration","volume":"169","author":"Schenk","year":"2002","journal-title":"J. Immunol."},{"issue":"22","key":"10.1016\/j.cyto.2017.09.013_b0600","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.1182\/blood-2012-09-459636","article-title":"The CXCR1\/2 ligand NAP-2 promotes directed intravascular leukocyte migration through platelet thrombi","volume":"121","author":"Ghasemzadeh","year":"2013","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.cyto.2017.09.013_b0605","doi-asserted-by":"crossref","first-page":"H1976","DOI":"10.1152\/ajpheart.00153.2005","article-title":"GRO family chemokines are specialized for monocyte arrest from flow","volume":"289","author":"Smith","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"1","key":"10.1016\/j.cyto.2017.09.013_b0610","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.yjmcc.2009.03.012","article-title":"Macrophage inflammatory protein-1beta induced cell adhesion with increased intracellular reactive oxygen species","volume":"47","author":"Tatara","year":"2009","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"3","key":"10.1016\/j.cyto.2017.09.013_b0615","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.yjmcc.2008.06.003","article-title":"CCL3 (MIP-1 alpha) levels are elevated during acute coronary syndromes and show strong prognostic power for future ischemic events","volume":"45","author":"de Jager","year":"2008","journal-title":"J. Mol. Cell. Cardiol."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466617302703?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466617302703?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T11:26:22Z","timestamp":1603452382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466617302703"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":123,"alternative-id":["S1043466617302703"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2017.09.013","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Platelet-derived chemokines in inflammation and atherosclerosis","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2017.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"154157"}}